basic_info |
|
| Product_Name: | 盐酸维拉帕米 |
| CAS: | 23313-68-0 ;152-11-4 ;52-53-9 |
| 中文同义词: | alpha-[3-[[2-(3,4-二甲氧苯基)乙基]甲氨基]丙基]-alpha-异丙基-3,4-二甲氧基苯乙腈盐酸盐 ; 维拉帕米盐酸盐 ; 盐酸维拉帕米 |
| EnglishSynonyms: | 2-(3,4-DIMETHOXYPHENYL)-5-[[2-(3,4-DIMETHOXYPHENYL)ETHYL](METHYL)AMINO]-2-ISOPROPYLPENTANENITRILE HYDROCHLORIDE ; (±)-VERAPAMIL HYDROCHLORIDE ; VIPROVERATRIL ; ISOPTIN HYDROCHLORIDE ; VERAPAMIL HCL ; 5-((3,4-DIMETHOXYPHENETHYL)METHYLAMINO)-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE ; (+/-)-VERAPAMIL HYDROCHLORIDE ; 5-[N-(3,4-DIMETHOXYPHENYLETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE ; VERAPAMIL HYDROCHLORIDE ; 2-(3,4-DIMETHOXYPHENYL)-5-([2-(3,4-DIMETHOXYPHENYL)ETHYL](METHYL)AMINO)-2-(PROPAN-2-YL)PENTANENITRILE HYDROCHLORIDE ; 5-((3,4-DIMETHOXYPHENETHYL)(METHYL)AMINO)-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLPENTANENITRILE HYDROCHLORIDE ; IPROVERATRIL ; CALAN ; BENZENEACETONITRILE, ALPHA-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-A-(1-METHYLETHYL)-, MONOHYDROCHLORIDE ; VERAPAMIL (HYDROCHLORIDE) ; 2-(3,4-DIMETHOXYPHENYL)-5-([2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO)-2-(METHYLETHYL)PENTANENITRILE, CHLORIDE ; CALAN HYDROCHLORIDE ; ISOPTIN ; ALPHA-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-ALPHA-(1-METHYLETHYL)-BENZENEACETONITRILE HYDROCHLORIDE ; ARPAMYL HYDROCHLORIDE ; IPROVERATRIL HYDROCHLORIDE |
| pro_mdlNumber: | MFCD00055208 |
| pro_acceptors: | 6 |
| pro_donors: | 0 |
| pro_smile: | CC(C)C(CCCN(C)CCc1ccc(c(c1)OC)OC)(C#N)c2ccc(c(c2)OC)OC.Cl |
| InChi: | InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H |
| InChiKey: | InChIKey=DOQPXTMNIUCOSY-UHFFFAOYSA-N |
property |
|
| MeltingPoint: | 142 DEG C (DEC)(LIT)/140-144℃ |
| Comments: | BIOCHEM/PHYSIOL ACTIONS: ALPHA1-ADRENOCEPTOR ANTAGONIST BIOCHEM/PHYSIOL ACTIONS: L-TYPE CALCIUM CHANNEL BLOCKER. BLOCKS L-TYPE CA2+ CHANNELS IN SMOOTH AND CARDIAC MUSCLE, INDUCES APOPTOSIS OF HUMAN PRIMARY AND METASTATIC COLON ADENOCARCINOMA CELLS IN VITRO. DRUG RESISTANCE REVERSAL AGENT ACTING ON PGP, EG DECREASE RENAL TUBULE ELIMINATION OF DIGOXIN. INCREASES BASAL ATPASE ACTIVITY OF PGP. SUBSTRATE OF CYP3A4 AND CYP2C6 RIDADR: UN 2811 6.1/PG 3 RTECS: YV8320000 UNSPSC: 12352100 WGK: 3 |
secure_info |
|
| secure_symbol: |
GHS06
|
| secure_signal_word: | Danger |
| secure_risk_stmt: | H301 + H311 + H331 |
| secure_cautionary_stmt: | P261-P280-P301 + P310-P311 |
| secure_damage_code: | T |
| secure_risk_disclosure_stmt: | R:23/24/25 |
| secure_security_stmt: | S:36/37-45 |
| secure_un_code: | 2811 |
| secure_wgk_germany: | 3 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2025 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1
浙公网安备 33010802004002号